同仁本草品牌怎么样 申请店铺

我要投票 同仁本草在保健药品行业中的票数:435 更新时间:2025-08-20
同仁本草是哪个国家的品牌?「同仁本草」是中国北京同仁堂(集团)有限责任公司旗下著名品牌。该品牌发源于北京,由创始人王贵平在1992-08-17期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力同仁本草品牌出海!将品牌入驻外推网,定制同仁本草品牌推广信息,可以显著提高同仁本草产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

同仁本草怎么样


“同仁本草”是北京同仁堂化妆品有限公司于2005年创建的首个子品牌,产品以“复方”草本植物提取精华原液为主要成分,已历经3代升级更新。

同仁本草从2005年创始至今,历经3代改革,不仅包装设计进行了升级,部分的产品配方进行了调整,生产工艺也进行了大幅度的改良。

现产品体系已经趋于完善,共分为5个系列,分别是美白修颜、补水莹透,抗皱驻颜、祛痘除印、体护系列;产品单品从2005年的22款单品扩展到现在的42款,其中美白修颜系列共计14个单品,补水莹透系列8个单品,抗皱驻颜系列12个单品,祛痘除印系列5个单品,体护系列3个单品。

从功能细分的角度,同仁本草的产品涵盖了洁面乳、化妆水、乳液、护肤霜、面膜、眼贴等主要的基础护肤品。

北京同仁堂化妆品有限公司,系北京同仁堂集团有限公司与香港国兴集团有限公司共同建立的中外合资企业。

北京同仁堂是中药行业著名的老字号,创建于清康熙八年(1669年),自雍正元年(1723年)正式供奉清皇宫御药房用药,历经八代皇帝,长达188年。历代同仁堂人恪守“炮制虽繁必不敢省人工品味虽贵必不敢减物力”的传统古训,树立“修合无人见存心有天知”的自律意识,确保了同仁堂金字招牌的长盛不衰。其产品以“配方独特、选料上乘、工艺精湛、疗效显著”而享誉海内外,产品行销40多个国家和地区。

目前,同仁堂已经形成了在集团整体框架下发展现代制药业、零售商业和医疗服务三大板块,配套形成十大公司、二大基地、二个院、二个中心的“1032”工程,其中拥有境内、境外两家上市公司,零售门店800余家,海外合资公司(门店)28家,遍布15个国家和地区。

拥有三百多年中医药背景的同仁堂是国药第一知名品牌。北京同仁堂化妆品有限公司结合其深厚的中医药美容理论,集合历代宫廷的养颜秘方,与现代化妆品研制技术,成功开发了以天然草本为原料的“同仁本草”、“伊妆”、“丽颜坊”以及特殊用途等系列中药化妆品。“同仁本草”系列于2003年上市,同仁堂以一贯倡导的“安全、有效”之产品开发理念,迎合现代人追求“回归自然、健康美颜”的消费需求,在国内推出中药的“药妆”产品,一经上市便得到了众多女性的青睐,在国内化妆品界引起了巨大反响。

公司本着“产品研发以市场为核心,营销以人性化为核心,售后以优质服务为中心,制定战略以成本为核心”经营理念,开展多种渠道结合的销售模式即:商场(百货/超市)、药房(店)及美容院(专业线),建立了以“同仁堂化妆品指定销售”形象专柜为主的销售终端。目前产品销售覆盖全国范围。


"Tongren Materia Medica" is the first sub brand created by Beijing Tongrentang Cosmetics Co., Ltd. in 2005. Its main ingredient is "compound" herbal extract, which has been upgraded for 3 generations. Tongren materia medica has undergone three generations of reform since its inception in 2005. Not only the packaging design has been upgraded, some product formulations have been adjusted, and the production process has been greatly improved. Now the product system has been improved, and it is divided into five series, namely whitening and repairing, moisturizing and translucent, anti wrinkle and anti acne and anti printing series, and body care series. The product single product has been expanded from 22 pieces in 2005 to 42 now, including 14 pieces in whitening and repairing series, 8 pieces in moisturizing and translucent series, 12 pieces in anti wrinkle and anti printing series, 5 pieces in anti acne and anti printing series, and body care series Series 3 pieces. From the perspective of functional segmentation, the products of Tongren materia medica include skin care products such as cleansing milk, make-up water, lotion, skin cream, facial mask, eye paste and so on. Beijing Tongrentang Cosmetics Co., Ltd. is a Sino foreign joint venture established by Beijing Tongrentang Group Co., Ltd. and Hong Kong Guoxing Group Co., Ltd. Beijing Tongrentang is a famous time-honored brand in the traditional Chinese medicine industry. It was founded in 1669, the eighth year of Kangxi in the Qing Dynasty. Since the year of yongzhengyuan (1723), it was officially dedicated to the Imperial Palace pharmacy of the Qing Dynasty. It has experienced eight generations of emperors for 188 years. All generations of Tongrentang people adhere to the traditional ancient maxim of "processing is too complicated to save artificial taste, expensive to reduce material resources", establish the self-discipline consciousness of "cultivating and combining without people's seeing and knowing", and ensure the long-term prosperity of Tongrentang's gold brand. Its products are well-known at home and abroad for "unique formula, excellent material selection, exquisite workmanship and remarkable curative effect". Its products are sold in more than 40 countries and regions. At present, Tongrentang has formed three parts: developing modern pharmaceutical industry, retail business and medical service under the overall framework of the group, supporting the "1032" project of ten companies, two bases, two hospitals and two centers, including two listed companies at home and abroad, more than 800 retail stores, 28 overseas joint ventures (stores), covering 15 countries and regions 。 Tongrentang, with more than 300 years of traditional Chinese medicine background, is the first famous brand of Chinese medicine. Beijing Tongrentang Cosmetics Co., Ltd. has successfully developed a series of traditional Chinese medicine cosmetics, such as Tongrentang Materia Medica, Yizhuang, liyanfang, and special uses, with natural herbs as raw materials, in combination with its profound theory of traditional Chinese medicine beauty and the secret recipes for beauty care of the imperial court of all ages and modern cosmetics development technology. "Tongrentang Materia Medica" series was launched in 2003. Tongrentang, with the consistent "safe and effective" product development concept, caters to the consumption demand of modern people in pursuit of "return to nature, health and beauty", launched the "medicated make-up" product of traditional Chinese medicine in China. Once it was launched, it was favored by many women and aroused great repercussions in the domestic cosmetics industry. Based on the business philosophy of "market as the core of product research and development, humanization as the core of marketing, high-quality service as the center of after-sales, and cost as the core of strategy formulation", the company has carried out the sales mode of combination of various channels, i.e. shopping malls (department stores / supermarkets), pharmacies (stores) and beauty salons (professional lines), and established a sales terminal focusing on the image counter of "Tongrentang cosmetics designated sales". At present, the product sales cover the whole country.

本文链接: https://brand.waitui.com/ae5ce8856.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

江波龙:员工持股平台拟合计减持公司不超1.31%股份

36氪获悉,江波龙公告,龙熹一号、龙熹二号、龙熹三号、龙舰管理、龙熹五号(统称“员工持股平台”)合计持有公司16.53%股份,计划在2025年9月11日至12月10日期间通过集中竞价交易方式和大宗交易方式合计减持公司股份不超过548万股(不超过公司总股本的1.31%)。

2小时前

云南锗业:公司及鑫耀公司目前并无6英寸磷化铟晶片规模化量产的具体计划

36氪获悉,云南锗业发布股票交易异常波动公告,公司了解到,近期有国内研发机构发布了其在6英寸磷化铟外延生长工艺领域实现了技术突破相关事宜。就控股子公司鑫耀公司而言,在2-4英寸规格的磷化铟晶片量产后,为应对未来的市场需求,对更大尺寸的产品开展了研究开发,但从研发到规模化生产尚存在较大不确定性。公司及鑫耀公司目前并无6英寸磷化铟晶片规模化量产的具体计划,下一步在市场与需求风险、技术风险等可控的前提下,公司方会考虑相关计划,如有相关计划,公司会按规定进行公开披露。

2小时前

胜宏科技:向香港联交所递交H股发行并上市申请并刊发申请资料

36氪获悉,胜宏科技公告,公司已于2025年8月20日向香港联交所递交了发行境外上市股份(H股)并在香港联交所主板挂牌上市的申请,并于同日在香港联交所网站刊登了本次发行的申请资料。该申请资料为草拟版本,其所载资料可能会适时作出更新及修订。公司本次发行尚需取得相关政府机关、监管机构、证券交易所的批准、核准或备案。

2小时前

永辉超市:上半年净亏损2.41亿元

36氪获悉,永辉超市公告,公司上半年实现营业总收入299.48亿元,同比下降20.73%;净亏损2.41亿元,上年同期盈利2.75亿元。

2小时前

摩根大通与三菱日联接近达成220亿美元的得州数据中心融资协议

英国《金融时报》周三报道,摩根大通和日本三菱日联金融集团正就为得克萨斯州一个数据中心承销220亿美元贷款展开谈判。报道称,该规划中的园区将由Vantage Data Centers所有,这是一家由银湖资本和资产管理公司DigitalBridge 控股的数字基础设施企业。报道还指出,银湖资本和DigitalBridge将合计承诺30亿美元股权,助力该数据中心园区的建设。(新浪财经)

2小时前

本页详细列出关于同仁本草的品牌信息,含品牌所属公司介绍,同仁本草所处行业的品牌地位及优势。
咨询